Clinical trial
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating…
NCT00003860 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00003860 |
|---|---|
| Title | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer |
| Official title | Intensive Chemotherapy With Peripheral Blood Stem Cell Support for Small Cell Lung Cancer |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | filgrastim, carboplatin, etoposide, ifosfamide, in vitro-treated peripheral blood stem cell transplantation |
| Enrollment | 36 |
| Start date | Sep 1, 1998 |
| Primary completion | Aug 1, 2000 |
| Completion | Sep 1, 2005 |
| First posted | Jun 16, 2004 |
| Last update posted | Feb 21, 2021 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: